Phenotype measures set:   McMullan7   VO2_n_end

ID, description, units MPD:61611   VO2_n_end   mean oxygen consumption after 4 wks of treatment, during night   [mL/h]
exercise study
Measures • no exercise group    • moderate intensity group    • high intensity group
Data set, strains McMullan7   CC   4 strains     sex: both     age: 8-10wks
Procedure monitoring system
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

McMullan7 - mean oxygen consumption after 4 wks of treatment, during night


Female

Male



  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

McMullan7 - mean oxygen consumption after 4 wks of treatment, during night





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 2 33623.9589 16811.9795 0.112 0.8941
sex 1 12960107.2998 12960107.2998 86.3316 < 0.0001
strain 3 7299533.9352 2433177.9784 16.2082 < 0.0001
group:sex 2 174946.418 87473.209 0.5827 0.5593
group:strain 6 2071606.1703 345267.695 2.2999 0.0358
sex:strain 3 1620651.2358 540217.0786 3.5986 0.0144
group:sex:strain 6 400517.6825 66752.9471 0.4447 0.8483
Residuals 214 32125702.6918 150120.106

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
McMullan7 61611 monitoring system exercise mean oxygen consumption after 4 wks of treatment, during night   [mL/h]   no exercise group   VO2_n_end_ctrl CC 4 both 8-10wks
McMullan7 61612 monitoring system exercise mean oxygen consumption after 4 wks of treatment, during night   [mL/h]   moderate intensity group   VO2_n_end_MICT CC 4 both 8-10wks
McMullan7 61613 monitoring system exercise mean oxygen consumption after 4 wks of treatment, during night   [mL/h]   high intensity group   VO2_n_end_HIIT CC 4 both 8-10wks